GI side effects. These are common with these medications and can include nausea, diarrhea, abdominal pain, and vomiting. “Symptoms are often tolerable in younger patients; they can precipitate serious ...

Colon cancer patients could live longer if they take GLP-1 drugs like Ozempic and Wegovy, a new study suggests. Researchers at UC San Diego studied more than 6,800 patients who were taking one of ...

Recent research has shown how weight-loss and diabetes medications, also known as glucagon-like peptide-1 receptor agonists (GLP-1s), can help with a variety of other conditions. This includes ...

The success and popularity of GLP-1 receptor agonists (RAs) for the treatment of patients with diabetes and obesity has led to intense interest in other potential effects of treatment, including ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and Mounjaro) had substantially lower five-year death rates than those not using ...

Around 4.1% of GB households are already using GLP-1 drugs, with further growth expected; Shifting demand for protein and fat could change the valorisation of milk produced in the ...

The discovery of GLP-1 and its role in regulating blood glucose was a major scientific breakthrough in diabetes research, yet turning this peptide hormone into an effective medication was no easy task ...